Sanofi (SNY) Event May 17, 2022, 19:20 UTC 13 1 comments (90% Positive) Sanofi (SNY) Announces Clinical Development Update (Form 6-K) Comment Full text
Genmab (GMAB) Event May 17, 2022, 18:39 UTC 13 1 comments (99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Comment Full text
Talaris Therapeutics Inc (TALS) Event May 17, 2022, 12:29 UTC 14 1 comments (99% Neutral) TALARIS THERAPEUTICS, INC. (TALS) Announces Clinical Development Update Comment Full text
Mereo BioPharma (MREO) Event May 17, 2022, 12:26 UTC 13 1 comments (35% Negative) Mereo BioPharma (MREO) Announces 2021 Annual General Meeting Comment Full text
Mereo BioPharma (MREO) Event May 17, 2022, 12:19 UTC 13 1 comments (99% Neutral) Mereo BioPharma (MREO) Announces Clinical Development Update (Form 6-K) Comment Full text
Ultragenyx Pharmaceutical Inc (RARE) Event May 17, 2022, 12:06 UTC 14 1 comments (10% Negative) Ultragenyx Pharmaceutical Inc. (RARE) Announces Delay in treatments Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Royalty Pharma (RPRX) Event May 17, 2022, 11:37 UTC 14 1 comments (100% Positive) Royalty Pharma plc (RPRX) Provides Update on opportunity for royalty funding in life sciences Comment Full text
Cytokinetics Inc (CYTK) Event May 17, 2022, 11:30 UTC 14 1 comments (75% Positive) Cytokinetics, Incorporated (CYTK) Announces Clinical Development Update Comment Full text
Aquestive Therapeutics Inc (AQST) Event May 17, 2022, 11:25 UTC 14 1 comments (99% Neutral) Aquestive Therapeutics, Inc. (AQST) Announces Business Combination Comment Full text
AVROBIO Inc (AVRO) Event May 17, 2022, 11:12 UTC 14 1 comments (10% Negative) AVROBIO, INC. (AVRO) Announces Delay in deficient Trials for Cystinosis Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text